Transdisciplinary Approach for Sarcopenia. Clinical significance of sarcopenia in the patients with chronic liver disease

Ken Shirabe; Norifumi Harimoto; Toru Ikegami; Tomoharu Yoshizumi; Shinji Itoh; kazuki takeishi; Takeo Toshima; Kohichi Kimura; Yoshihiro Matsumoto; Yuki Bekki; Daisuke Imai; Yoichi Yamashita; Hirofumi Kawanaka; Yoshihiko Maehara

Transdisciplinary Approach for Sarcopenia. Clinical significance of sarcopenia in the patients with chronic liver disease

Ken Shirabe, Norifumi Harimoto, Toru Ikegami, Tomoharu Yoshizumi, Shinji Itoh, kazuki takeishi, Takeo Toshima, Kohichi Kimura, Yoshihiro Matsumoto, Yuki Bekki, Daisuke Imai, Yoichi Yamashita, Hirofumi Kawanaka, Yoshihiko Maehara

Research output: Contribution to journal › Article › peer-review

Abstract

Recently, many studies of the patients with chronic liver disease have focused on sarcopenia. In the patients with chronic liver disease, sarcopenia occurs, because of advanced liver failure and hepatocellular carcinoma (HCC) . In both diseases, sarcopenia is an important prognostic factor. Thus, sarcopenia has been reported to be a predictor for recurrence of HCC and early mortality after liver transplantation. In the patients with HCC, the mechanism of sarcopenia is unknown. In the patients with endostea liver failure, muscle compensates energy breakdown of the liver and muscle atrophy occurs. Further research is necessary to clarify whether nutritional support and muscle training prevent from sarcopenia and as a result, improve survival of the patients with chronic liver disease.

Original language	English
Pages (from-to)	1493-1499
Number of pages	7
Journal	Clinical calcium
Volume	24
Issue number	10
Publication status	Published - Oct 1 2014

All Science Journal Classification (ASJC) codes

Medicine(all)

Cite this

@article{0ad51aef725e4d2bad82dbbd8fe56f81,

title = "Transdisciplinary Approach for Sarcopenia. Clinical significance of sarcopenia in the patients with chronic liver disease",

abstract = "Recently, many studies of the patients with chronic liver disease have focused on sarcopenia. In the patients with chronic liver disease, sarcopenia occurs, because of advanced liver failure and hepatocellular carcinoma (HCC) . In both diseases, sarcopenia is an important prognostic factor. Thus, sarcopenia has been reported to be a predictor for recurrence of HCC and early mortality after liver transplantation. In the patients with HCC, the mechanism of sarcopenia is unknown. In the patients with endostea liver failure, muscle compensates energy breakdown of the liver and muscle atrophy occurs. Further research is necessary to clarify whether nutritional support and muscle training prevent from sarcopenia and as a result, improve survival of the patients with chronic liver disease. ",

author = "Ken Shirabe and Norifumi Harimoto and Toru Ikegami and Tomoharu Yoshizumi and Shinji Itoh and kazuki takeishi and Takeo Toshima and Kohichi Kimura and Yoshihiro Matsumoto and Yuki Bekki and Daisuke Imai and Yoichi Yamashita and Hirofumi Kawanaka and Yoshihiko Maehara",

year = "2014",

month = oct,

day = "1",

language = "English",

volume = "24",

pages = "1493--1499",

journal = "Clinical calcium",

issn = "0917-5857",

publisher = "Iyaku (Medicine & Drug) Journal Co",

number = "10",

}

TY - JOUR

T1 - Transdisciplinary Approach for Sarcopenia. Clinical significance of sarcopenia in the patients with chronic liver disease

AU - Shirabe, Ken

AU - Harimoto, Norifumi

AU - Ikegami, Toru

AU - Yoshizumi, Tomoharu

AU - Itoh, Shinji

AU - takeishi, kazuki

AU - Toshima, Takeo

AU - Kimura, Kohichi

AU - Matsumoto, Yoshihiro

AU - Bekki, Yuki

AU - Imai, Daisuke

AU - Yamashita, Yoichi

AU - Kawanaka, Hirofumi

AU - Maehara, Yoshihiko

PY - 2014/10/1

Y1 - 2014/10/1

N2 - Recently, many studies of the patients with chronic liver disease have focused on sarcopenia. In the patients with chronic liver disease, sarcopenia occurs, because of advanced liver failure and hepatocellular carcinoma (HCC) . In both diseases, sarcopenia is an important prognostic factor. Thus, sarcopenia has been reported to be a predictor for recurrence of HCC and early mortality after liver transplantation. In the patients with HCC, the mechanism of sarcopenia is unknown. In the patients with endostea liver failure, muscle compensates energy breakdown of the liver and muscle atrophy occurs. Further research is necessary to clarify whether nutritional support and muscle training prevent from sarcopenia and as a result, improve survival of the patients with chronic liver disease.

AB - Recently, many studies of the patients with chronic liver disease have focused on sarcopenia. In the patients with chronic liver disease, sarcopenia occurs, because of advanced liver failure and hepatocellular carcinoma (HCC) . In both diseases, sarcopenia is an important prognostic factor. Thus, sarcopenia has been reported to be a predictor for recurrence of HCC and early mortality after liver transplantation. In the patients with HCC, the mechanism of sarcopenia is unknown. In the patients with endostea liver failure, muscle compensates energy breakdown of the liver and muscle atrophy occurs. Further research is necessary to clarify whether nutritional support and muscle training prevent from sarcopenia and as a result, improve survival of the patients with chronic liver disease.

UR - http://www.scopus.com/inward/record.url?scp=85016502237&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85016502237&partnerID=8YFLogxK

M3 - Article

C2 - 25266095

AN - SCOPUS:85016502237

SN - 0917-5857

VL - 24

SP - 1493

EP - 1499

JO - Clinical calcium

JF - Clinical calcium

IS - 10

ER -

Transdisciplinary Approach for Sarcopenia. Clinical significance of sarcopenia in the patients with chronic liver disease

Abstract

All Science Journal Classification (ASJC) codes

Other files and links

Fingerprint

Cite this